DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: Alzheimer

News

US Merck Discontinues Alzheimer’s Drug Trial

16.02.2018 - US drugmaker Merck & Co. has said it will halt its APECS randomized, placebo-controlled, parallel-group, double-blind Phase 3 clinical trial evaluating the efficacy and safety of...

News

Allergan and Heptares in Neurological Drugs Deal

12.04.2016 - Allergan Pharmaceuticals International, a wholly owned subsidiary of Ireland-based Allergan, has entered a definitive agreement with British biotech firm Heptares to license...

News

Eli Lilly Raises Hope of Alzheimer’s Breakthrough

29.07.2015 - A new experimental Alzheimer’s drug, solanezumab, developed by Eli Lilly has raised hopes for a breakthrough in the treatment of the disease. The progress was reported at the...

News

Roche Alzheimer's Drug Fails Main Goals in Mid-stage Study

17.07.2014 - Swiss drugmaker Roche said its experimental Alzheimer's drug failed to meet its main goals in a mid-stage study, a result likely to bolster the belief that drugs need to be given...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.